NDC 25021-755 – Famotidine
Famotidine 4 mg/mL · Injection, Solution · Intravenous
Product NDC25021-755
Product details
- Brand name
- Famotidine
- Generic name
- Famotidine
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA219935
- Marketed since
- October 15, 2025
- Marketing end
- July 31, 2027
- Pharmacologic class
- Histamine-2 Receptor Antagonist
Active ingredients
- Famotidine 4 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 25021-755-05 | 25 VIAL in 1 CARTON (25021-755-05) / 5 mL in 1 VIAL | Oct 15, 2025 |
Other Famotidine products
- 0338-5197 Famotidine 20 mg/50mL · Injection, Solution · Baxter Healthcare Corporation
- 63323-738 Famotidine 10 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 63323-739 Famotidine 10 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 51662-1375 Famotidine 10 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 71872-7366 Famotidine 10 mg/mL · Injection, Solution · Medical Purchasing Solutions, LLC
- 25021-754 Famotidine 10 mg/mL · Injection, Solution · Sagent Pharmaceuticals
- 25021-756 Famotidine 4 mg/mL · Injection, Solution · Sagent Pharmaceuticals
- 25021-753 Famotidine 10 mg/mL · Injection, Solution · Sagent Pharmaceuticals
- 50090-6582 Famotidine 20 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-7178 Famotidine 20 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-1432 Famotidine 40 mg/1 · Tablet · A-S Medication Solutions
- 50090-1044 Famotidine 20 mg/1 · Tablet, Film Coated · A-S Medication Solutions